methylprednisolone and idelalisib

methylprednisolone has been researched along with idelalisib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Budziszewska, BK; Długosz-Danecka, M; Gil, L; Hus, M; Iskierka-Jażdżewska, E; Jamroziak, K; Jurczak, W; Lech-Marańda, E; Osowiecki, M; Piszczek, W; Puła, B; Rybka, J; Salomon-Perzyński, A; Steckiewicz, P; Subocz, E; Szukalski, Ł; Szymczyk, A; Waszczuk-Gajda, A; Zaucha, JM	1

Other Studies

1 other study(ies) available for methylprednisolone and idelalisib

Article	Year
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors. Advances in medical sciences, 2020, Volume: 65, Issue:2 Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Prognosis; Proto-Oncogene Proteins c-bcr; Purines; Quinazolinones; Retrospective Studies; Salvage Therapy; Survival Rate; Tumor Suppressor Protein p53	2020

Article

Year

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors.

Advances in medical sciences, 2020, Volume: 65, Issue:2

Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Prognosis; Proto-Oncogene Proteins c-bcr; Purines; Quinazolinones; Retrospective Studies; Salvage Therapy; Survival Rate; Tumor Suppressor Protein p53

2020